These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23496132)

  • 1. Drug discovery for hyperuricemia.
    Anzai N; Endou H
    Expert Opin Drug Discov; 2007 Sep; 2(9):1251-61. PubMed ID: 23496132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urate transport across the apical membrane of renal proximal tubules.
    Endou H; Anzai N
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):578-84. PubMed ID: 18600508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into renal transport of urate.
    Anzai N; Kanai Y; Endou H
    Curr Opin Rheumatol; 2007 Mar; 19(2):151-7. PubMed ID: 17278930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout.
    Dalbeth N; Merriman T
    Rheumatology (Oxford); 2009 Mar; 48(3):222-6. PubMed ID: 19109320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
    Torralba KD; De Jesus E; Rachabattula S
    Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urate transporter and renal hypouricemia].
    Enomoto A; Niwa T; Kanai Y; Endou H
    Rinsho Byori; 2003 Sep; 51(9):892-7. PubMed ID: 14560659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of renal uric acid excretion and gout.
    Taniguchi A; Kamatani N
    Curr Opin Rheumatol; 2008 Mar; 20(2):192-7. PubMed ID: 18349750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Influence of Genetic Variants of
    Pavelcova K; Bohata J; Pavlikova M; Bubenikova E; Pavelka K; Stiburkova B
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32759716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urate transporter URAT1 inhibitors: a patent review (2012 - 2015).
    Pan Y; Kong LD
    Expert Opin Ther Pat; 2016 Oct; 26(10):1129-1138. PubMed ID: 27414413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
    Perez-Ruiz F; Herrero-Beites AM; Carmona L
    Arthritis Rheum; 2011 Dec; 63(12):4002-6. PubMed ID: 21898351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-uricase in the management of treatment-resistant gout and hyperuricemia.
    Sherman MR; Saifer MG; Perez-Ruiz F
    Adv Drug Deliv Rev; 2008 Jan; 60(1):59-68. PubMed ID: 17826865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apical voltage-driven urate efflux transporter NPT4 in renal proximal tubule.
    Jutabha P; Anzai N; Wempe MF; Wakui S; Endou H; Sakurai H
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1302-11. PubMed ID: 22132991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of urate-lowering therapies: managing the risks to gain the benefits.
    Keenan RT
    Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of SLC2A9 decreases urate excretion from the kidney.
    Kimura T; Amonpatumrat S; Tsukada A; Fukutomi T; Jutabha P; Thammapratip T; Lee EJ; Ichida K; Anzai N; Sakurai H
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1295-301. PubMed ID: 22132990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperuricemia due to decreased renal uric acid excretion].
    Yamauchi T; Ueda T
    Nihon Rinsho; 2008 Apr; 66(4):679-81. PubMed ID: 18409514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the pharmacotherapy of gout.
    Sundy JS
    Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.